ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near San Antonio, TX, USA:

Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer and triple ne ...

Active, not recruiting
Metastatic Breast Cancer
Triple Negative Breast Cancer
Drug: PMD-026

Phase 1

Phoenix Molecular Designs

San Antonio, Texas, United States and 8 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Enrolling
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

San Antonio, Texas, United States of America and 10 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Enrolling
Breast Cancer
Locally Advanced Breast Cancer
Drug: Elacestrant Dihydrochloride
Drug: Samuraciclib

Phase 1, Phase 2

Carrick Therapeutics

San Antonio, Texas, United States and 26 other locations

positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. The main pu...

Enrolling
Hormone-receptor-positive Breast Cancer
Non-small Cell Lung Cancer
Drug: BGB-43395
Drug: Fulvestrant

Phase 1

BeiGene
BeiGene

San Antonio, Texas, United States and 8 other locations

to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combination with Fulvestrant in advanced breast...

Enrolling
Breast Cancer
Advanced Solid Tumor
Drug: CFI-402257
Drug: Fulvestrant

Phase 1, Phase 2

Treadwell Therapeutics

San Antonio, Texas, United States of America and 3 other locations

doxorubicin (PLD, Doxil) are safe and effective at controlling the cancer in patients with metastatic triple negative breast cancer...

Enrolling
Metastatic Triple Negative Breast Cancer
Drug: CDX-1140
Drug: PLD Chemotherapy

Phase 1

The University of Texas System (UT)
The University of Texas System (UT)

San Antonio, Texas, United States and 5 other locations

study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

San Antonio, Texas, United States and 75 other locations

ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The...

Invitation-only
Breast Cancer
Drug: TOL2506
Drug: Letrozole tablets

Phase 3

Tolmar Pharmaceuticals

New Braunfels, Texas, United States and 10 other locations

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer...

Active, not recruiting
Breast Cancer
Drug: Letrozole
Other: Placebo

Phase 3

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

San Antonio, Texas, United States and 805 other locations

in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...

Enrolling
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Datopotamab deruxtecan

Phase 1, Phase 2

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 46 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems